您当前所在位置:首页 > 材料科学 > 新品上市
序号 标题 次数 作者 发布时间
75736 MAL-di-EG-Val-Cit-PAB-MMAF, ADC试剂 85 kx 2024-12-19
75737 cas:2353409-45-5 endo BCN-PEG3-VC-PFP Ester 98 zyl 2024-12-19
75738 Hydrazone-doxorubicin, ADC试剂 169 kx 2024-12-19
75739 DBCO-C4-Val-Cit-PABC-PNP 77 zyl 2024-12-19
75740 cas:644981-35-1 Val-Cit-PAB-MMAE 84 zyl 2024-12-19
75741 cas:170908-81-3,DOTA-NHS ester ,1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸 1-(2,5-二氧代-1-吡咯烷基)酯 73 kx 2024-12-19
75742 endo-BCN-PEG4-Val-Cit-PAB-MMAE的介绍 82 zyl 2024-12-19
75743 cas:2259318-50-6,MA-PEG4-VA-PBD , ADC试剂 97 kx 2024-12-19
75744 CAS: 2259318-55-1 - DBCO-(PEG2-VC-PAB-MMAE)2 65 WYQ 2024-12-19
75745 CAS: 2768446-73-5,DBCO-Val-Cit-PAB-MMAE 79 WYQ 2024-12-19
75746 MC-vc-PAB-C6-a-amanitin, ADC试剂 70 kx 2024-12-19
75747 cas:663598-98-9,2,5-dioxopyrrolidin-1-yl 4-methyl-4-((5-nitropyridin-2-yl)disulfanyl)pentanoate,ADC定制 90 wyh 2024-12-19
75748 cas:2873452-49-2 MC-EVCit-PAB-MMAE 87 zyl 2024-12-19
75749 2,5-dioxopyrrolidin-1-yl 3-methyl-3-(pyridin-2-yldisulfanyl)butanoate,ADC定制 95 wyh 2024-12-19
75750 cas:159857-70-2 MC-Val-Cit-Doxorubicin 118 zyl 2024-12-19
75751 Gly3-vc-PAB-MMAE, ADC试剂 103 kx 2024-12-19
75752 CAS: 1869126-64-6, Azido-PEG4-Val-Cit-PAB-MMAE 87 WYQ 2024-12-19
75753 cas:2353409-54-6 , Mal-amido-PEG8-Val-Gly,ADC定制 104 wyh 2024-12-19
75754 Azido-PEG4-Val-Ala-PAB-PNP 99 zyl 2024-12-19
75755 NOTA-(NGR)2 NOTA偶联NGR二聚体 78 h 2024-12-19
75756 1-(2,5-dioxopyrrolidin-1-yloxy)-4-((5-nitropyridin-2-yl)disulfanyl)-1-oxobutane-2-sulfonic acid,ADC定制 89 wyh 2024-12-19
75757 CAS: 1343476-44-7,Val-Ala-PAB-OH 79 WYQ 2024-12-19
75758 MC-PBD, ADC试剂 88 kx 2024-12-19
75759 Mal-Val-Ala-PAB的介绍 90 zyl 2024-12-19
75760 DOTA-K-A9 1,4,7,10-四氮杂环十二烷-N,N,N,N-四乙酸(DOTA)结合肽A9 79 h 2024-12-19
75761 Azide-PEG3-Val-Cit-PAB-MMAF,叠氮-三聚乙二醇-Val-Cit-PAB-MMAF 83 WYQ 2024-12-19
75762 Arm-DOTA-B72.3 77 h 2024-12-19
75763 cas:1884577-99-4 Boc-Val-Ala-PAB 93 zyl 2024-12-19
75764 (Lys(DOTA)4)BVD15 DOTA偶联神经肽Y(NPY)类似物 126 h 2024-12-19
75765 1801838-28-7,Mc-vc-PAB-SN38,化合物MC-VC-PAB-SN38 87 kx 2024-12-19
75766 DOTA-PPI 1,4,7,10-四氮杂环十二烷-N,N,N,N-四乙酸(DOTA)-官能化的聚(丙烯亚胺)(PPI)糖树枝状分子 89 h 2024-12-19
75767 CAS: 863971-17-9,MC-Val-Cit-PAB-MMAF 110 WYQ 2024-12-19
75768 cas:1884577-99-4 Boc-Val-Ala-PAB 124 zyl 2024-12-19
75769 DBCO-PEG4-vc-PAB-MMAE, ADC试剂 112 kx 2024-12-19
75770 1884578-00-0,Boc-PEG4-Val-Ala-PAB-PNP,ADC定制 114 wyh 2024-12-19
75771 DOTA-Peg-Cpa-c[DCys-Aph(Cbm)-DTrp-Lys-Thr-Cys]-2Nal-NH2 77 h 2024-12-19
75772 DOTA-2.5D DOTA-胱氨酸结肽(knottins)2.5D和2.5F 94 h 2024-12-19
75773 二苯并环辛炔-四聚乙二醇-VAL-ALA-PAB,ADC定制 114 wyh 2024-12-19
75774 Hz220(DOTA-Lys(IR dye 650)-PEa(4)-[D-Phe(6)DOTA偶联的GRPr拮抗剂 91 h 2024-12-19
75775 Azido-PEG4-MMAE,抗体药物偶联物(ADCs) 123 WYQ 2024-12-19
75776 1626359-62-3,SPDB-DM4, ADC试剂 81 kx 2024-12-19
75777 Acid-PEG4-Val-Cit-PAB-MMAE,包含PEG链和MMAE等部分 87 WYQ 2024-12-19
75778 cas:159857-70-2,MC-Val-Cit-Doxorubicin,ADC定制 110 wyh 2024-12-19
75779 DOTA-(D)Phe(1)-Tyr(3) 82 h 2024-12-19
75780 cas:1884577-99-4 Boc-Val-Ala-PAB 123 zyl 2024-12-19
库存查询